WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

Weight loss drugs can halve heart patients’ risk of early death, study finds

GLP-1 agonists could be given to millions with heart conditions to help them stay out of hospital and live longer

Raccontata daindependent.co.uktheguardian.comtelegraph.co.uk

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
theguardian.comStai leggendo10 mesi fa

Weight loss drugs can halve heart patients’ risk of early death, study finds

GLP-1 agonists could be given to millions with heart conditions to help them stay out of hospital and live longer

originale
telegraph.co.uk10 mesi fa

Weight loss jabs could halve risk of death in heart patients, study finds

Anti-obesity injections like Mounjaro and Wegovy could help people with cardiovascular diseases stay out of hospital and live longer

Leggi questa versione → originale
independent.co.uk10 mesi fa

Weight loss jabs could keep heart failure patients out of hospital

Semaglutide and Tirzepatide could help patients with heart condition HFpEF

Leggi questa versione → originale

Timeline cronologica

  1. domenica 31 agosto 2025·independent.co.uk

    Weight loss jabs could keep heart failure patients out of hospital

    Semaglutide and Tirzepatide could help patients with heart condition HFpEF

  2. domenica 31 agosto 2025·theguardian.com

    Weight loss drugs can halve heart patients’ risk of early death, study finds

    GLP-1 agonists could be given to millions with heart conditions to help them stay out of hospital and live longer

  3. domenica 31 agosto 2025·telegraph.co.uk

    Weight loss jabs could halve risk of death in heart patients, study finds

    Anti-obesity injections like Mounjaro and Wegovy could help people with cardiovascular diseases stay out of hospital and live longer